Christian Herrmann1, Rudolf Morant2, Esther Walser3, Mohsen Mousavi3, Beat Thürlimann4,5. 1. Cancer Registry of Eastern Switzerland, Cancer League of Eastern Switzerland, St. Gallen, Switzerland. christian.herrmann@krebsregister-ost.ch. 2. Cancer League of Eastern Switzerland, St. Gallen, Switzerland. 3. Cancer Registry of Eastern Switzerland, Cancer League of Eastern Switzerland, St. Gallen, Switzerland. 4. Division Oncology-Haematology, Department of Internal Medicine, St. Gallen, Switzerland. 5. Breast Centre St.Gallen, Cantonal Hospital, St. Gallen, Switzerland.
Abstract
BACKGROUND: A recent study found an influence of organized mammography screening programmes (MSPs) on geographical and temporal variation of mastectomy rates. We aimed to quantify the effect on the example of one of the cantonal programmes in Switzerland. METHODS: We used incidence data for the years 2010-2017 from the cancer registry of Eastern Switzerland. We included women with invasive-non-metastatic breast cancer (BC) in the screening age group 50-69-year-olds in the canton of St.Gallen. We compared mastectomy rates among cancer patients detected through the organised screening programme (MSP) vs. otherwise detected by stage. RESULTS: MSP-detected patients in St.Gallen presented with lower stages. 95% of MSP-detected had stages I-II vs 76% of Non-MSP-detected. Within all non-metastatic stage, tumour size and nodal status groups, MSP-detected patients had lower mastectomy rates, overall 10% vs 24% in 50-69-year-old non-participants. Their odds of receiving a mastectomy are about half of the Non-MSP-detected (OR = 0.48, p = 0.002). CONCLUSIONS: Our study showed that MSPs have a positive effect on lowering mastectomy rates. Screening participants are significantly less likely to receive a mastectomy compared to non-participants, which must be attributed to additional factors than just lower stages. Lower mastectomy rates lead to a higher quality of life for many patients.
BACKGROUND: A recent study found an influence of organized mammography screening programmes (MSPs) on geographical and temporal variation of mastectomy rates. We aimed to quantify the effect on the example of one of the cantonal programmes in Switzerland. METHODS: We used incidence data for the years 2010-2017 from the cancer registry of Eastern Switzerland. We included women with invasive-non-metastatic breast cancer (BC) in the screening age group 50-69-year-olds in the canton of St.Gallen. We compared mastectomy rates among cancerpatients detected through the organised screening programme (MSP) vs. otherwise detected by stage. RESULTS: MSP-detected patients in St.Gallen presented with lower stages. 95% of MSP-detected had stages I-II vs 76% of Non-MSP-detected. Within all non-metastatic stage, tumour size and nodal status groups, MSP-detected patients had lower mastectomy rates, overall 10% vs 24% in 50-69-year-old non-participants. Their odds of receiving a mastectomy are about half of the Non-MSP-detected (OR = 0.48, p = 0.002). CONCLUSIONS: Our study showed that MSPs have a positive effect on lowering mastectomy rates. Screening participants are significantly less likely to receive a mastectomy compared to non-participants, which must be attributed to additional factors than just lower stages. Lower mastectomy rates lead to a higher quality of life for many patients.
Entities:
Keywords:
Breast cancer; Epidemiology; Mammography screening programme; Mastectomy; Public health; Switzerland
Authors: Eugenio Paci; Stephen W Duffy; Daniela Giorgi; Marco Zappa; Emanuele Crocetti; Vania Vezzosi; Simonetta Bianchi; Luigi Cataliotti; Marco Rosselli del Turco Journal: BMJ Date: 2002-08-24
Authors: Maire Brid Mac Bride; Lonzetta Neal; Christina A Dilaveri; Nicole P Sandhu; Tina J Hieken; Karthik Ghosh; Dietlind L Wahner-Roedler Journal: J Womens Health (Larchmt) Date: 2013-02-21 Impact factor: 2.681
Authors: U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali Journal: N Engl J Med Date: 1981-07-02 Impact factor: 91.245
Authors: Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark Journal: N Engl J Med Date: 2002-10-17 Impact factor: 91.245